Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition

Our findings point to intratumoral heterogeneity as a limiting factor in the use of DNA methyltransferase inhibitors as single agents in treatment of solid cancers and highlight histone deacetylase inhibitors as essential partners to DNA methyltransferase inhibitors in the clinic.

Authors

Institutions

Publication Details

Journal
Journal of Experimental & Clinical Cancer Research
Published
2025-01-23
DOI
https://doi.org/10.1186/s13046-025-03294-x
Citations
7
Primary Topic
Epigenetics and DNA Methylation
Type
article
Field-Weighted Citation Impact
5.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition

Mikkel G. Terp, Sofie Traynor, Anup Shrestha, Henrik J. Ditzel et al.
7 citations
Journal of Experimental & Clinical Cancer Research
Epigenetics and DNA Methylation
5.64
article

Stochastic demethylation and redundant epigenetic suppressive mechanisms generate highly heterogeneous responses to pharmacological DNA methyltransferase inhibition

Mikkel G. Terp, Sofie Traynor, Anup Shrestha, Henrik J. Ditzel, Aaraby Nielsen, Christina Dahl, Jonathan R. Brewer, Maria S. Madsen, Odd Lilleng Gammelgaard, Mie K. Jakobsen, Per Guldberg, Josefine B. Jensen, Mette Stæhr, Pascal H. G. Duijf, Simon T. Jakobsen, Morten F. Gjerstorff, Alexei F. Kirkin, Rasmus Siersbæk, Christina B. Pedersen
article en
7 citations

Abstract

Our findings point to intratumoral heterogeneity as a limiting factor in the use of DNA methyltransferase inhibitors as single agents in treatment of solid cancers and highlight histone deacetylase inhibitors as essential partners to DNA methyltransferase inhibitors in the clinic.

Journal of Experimental & Clinical Cancer ResearchVol. 44(1)
South Australia Pathology (AU), Oslo University Hospital (NO), University of South Australia (AU), University of Southern Denmark (DK), University of Oslo (NO), Odense University Hospital (DK), Centre for Cancer Biology (AU), Danish Cancer Society (DK), Danish Diabetes Academy (DK), Cytovac (Denmark) (DK)
Dagmar Marshalls Fond, Kræftens Bekæmpelse, Villum Fonden, Agnes og Poul Friis Fond, Syddansk Universitet, Frimodt-Heineke Fonden, Novo Nordisk Fonden
Good health and well-being
Openalex Percentile: Top 4%
Epigenetics and DNA Methylation
5.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.